1. Lee, Jin-Kwan, Ha, Geun-Hyoung, Kim, Hyun-Soo, Lee, Chang-Woo. 2018. Oncogenic potential of BEX4 is conferred by Polo-like kinase 1-mediated phosphorylation. In Experimental & molecular medicine, 50, 1-12. doi:10.1038/s12276-018-0168-0. https://pubmed.ncbi.nlm.nih.gov/30367032/
2. Lee, Jin-Kwan, Lee, Janet, Go, Heounjeong, Ha, Geun-Hyoung, Lee, Chang-Woo. 2016. Oncogenic microtubule hyperacetylation through BEX4-mediated sirtuin 2 inhibition. In Cell death & disease, 7, e2336. doi:10.1038/cddis.2016.240. https://pubmed.ncbi.nlm.nih.gov/27512957/
3. Zhao, Ziran, Li, Jiagen, Tan, Fengwei, Gao, Shugeng, He, Jie. 2018. mTOR up-regulation of BEX4 promotes lung adenocarcinoma cell proliferation by potentiating OCT4. In Biochemical and biophysical research communications, 500, 302-309. doi:10.1016/j.bbrc.2018.04.064. https://pubmed.ncbi.nlm.nih.gov/29660335/
4. Alvarez, Enrique, Zhou, Wenbo, Witta, Samir E, Freed, Curt R. . Characterization of the Bex gene family in humans, mice, and rats. In Gene, 357, 18-28. doi:. https://pubmed.ncbi.nlm.nih.gov/15958283/
5. Gao, Wei, Li, John Zeng-Hong, Chen, Si-Qi, Chan, Jimmy Yu-Wai, Wong, Thian-Sze. 2016. Decreased brain-expressed X-linked 4 (BEX4) expression promotes growth of oral squamous cell carcinoma. In Journal of experimental & clinical cancer research : CR, 35, 92. doi:10.1186/s13046-016-0355-6. https://pubmed.ncbi.nlm.nih.gov/27297407/
6. Li, Ziyao, Xin, Shiyong, Huang, Liqun, Wang, Wenwen, Ye, Lin. 2024. BEX4 inhibits the progression of clear cell renal cell carcinoma by stabilizing SH2D4A, which is achieved by blocking SIRT2 activity. In Oncogene, 44, 665-678. doi:10.1038/s41388-024-03235-6. https://pubmed.ncbi.nlm.nih.gov/39639172/
7. Zhu, Chenhong, Xiao, Deshuang. . Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer. In Medicine, 99, e23133. doi:10.1097/MD.0000000000023133. https://pubmed.ncbi.nlm.nih.gov/33217815/
智鼠故事 
